Baker Bros. Advisors’s Tango Therapeutics TNGX Stock Holding History
Bought
Maintained
Sold
Other funds holding TNGX
SL
Baker Bros. Advisors's TNGX Position: Q3 2026 in Review
Baker Bros. Advisors held its Tango Therapeutics (TNGX) position steady in Q3 2026 at 333,333 shares worth $8.32M. The position accounts for 0.04% of the portfolio, ranked #68.
Baker Bros. Advisors first reported a position in TNGX in Q3 2021 and has held it in 15 quarters since. The position peaked at $10.4M in Q2 2026. 257 funds tracked by Wall St. Rank hold TNGX as of Q3 2026.
- Baker Bros. Advisors held 333,333 shares of Tango Therapeutics worth $8.32M as of Q3 2026.
- Baker Bros. Advisors left its Tango Therapeutics share count unchanged in Q3 2026.
- Tango Therapeutics made up 0.04% of Baker Bros. Advisors's portfolio in Q3 2026, its #68 holding.
- Baker Bros. Advisors first reported a position in Tango Therapeutics in Q3 2021 and has held it in 15 quarters since.
- Baker Bros. Advisors's Tango Therapeutics position peaked at $10.4M in Q2 2026.
- 257 funds tracked by Wall St. Rank held Tango Therapeutics as of Q3 2026.
Based on Baker Bros. Advisors's 13F filing for Q3 2026, filed 16 Nov 2026.